Phase 1 study of ramucirumab (R) plus durvalumab (D) in patients (pts) with locally advanced and unresectable or metastatic gastrointestinal or thoracic malignancies (NCT02572687); Phase 1a results - Concepedia

Concepedia

Publication | Closed Access

Phase 1 study of ramucirumab (R) plus durvalumab (D) in patients (pts) with locally advanced and unresectable or metastatic gastrointestinal or thoracic malignancies (NCT02572687); Phase 1a results

10

Citations

0

References

2016

Year

C.-C. Lin, Talia Golan, J. Corral, Vicente Moreno, Hyun Cheol Chung, Heather Wasserstrom, Jing Yang, Gu Mi, Y. Bang

Annals of Oncology

No additional data available for this publication yet. Check back later!